Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
Yehuda Carmeli*, Jon Armstrong, Peter J. Laud, Paul Newell, Greg Stone, Angela Wardman, Leanne B. Gasink
Research output: Contribution to journal › Article › peer-review
342Scopus
citations
Fingerprint
Dive into the research topics of 'Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study'. Together they form a unique fingerprint.